Hutch News
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Taking the shortcut to frontline treatment
From Dr. Schmitt and the Radich lab, Clinical Research Division
Lyani Valle: leukemia survivor, Obliteride walker
'Cancer was a huge wake-up call to what is important in life'
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Health disparities may affect end-of-life experiences of minority blood cancer patients
A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients
KUOW profiles E. Donnall Thomas and his Nobel Prize-winning work on a once 'radical' cure for leukemia
Fred Hutch research in bone marrow transplantation helped establish Seattle's biotech industry
Fred Hutch scientist awarded Hyundai Scholar Hope Grant for childhood leukemia research
$250,000 grant to support Dr. Cecilia Yeung’s work on pediatric acute leukemia
Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy
Fred Hutch expert comments on FDA approval of new Novartis immunotherapy drug CTL019 — August 30, 2017
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Remembering leukemia researcher Dr. Steve Collins
Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more
The human version makes it better
from the Riddell lab (Clinical Research Division)
Good News: Innovator award to Dr. Marie Bleakley for new leukemia immunotherapies
Celebrating faculty and staff achievements
Capturing information from thousands of cells at once
New technology allows scientists to peek inside nearly 70,000 cells in single experiment
.jpg)
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis
Sorting stem cells before transplant helps lower risk of graft-vs.-host disease, researcher reports at ASH
Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports
'Kids are not little adults'
Why children with cancer need their own drugs and their own research
Chance of surviving childhood cancer has improved — but survivors’ overall health has not
In large study of childhood cancer survivors, self-reported health remained constant or declined for patients treated in recent decades
Common genetic disorder linked to increased death rate from cancer drug
Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
New approach aims to restore immune-powering B cells in cancer patients following successful immunotherapy with CAR T cells
New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy
Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award
Celebrating faculty and staff achievements